Saladaga, Roselyn M.
HRN: 10-15-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/06/2022
11/09/2022
IVT
4.5g
Q6
Sepsis, CAP-HR, Hypoxic Encephalopathy
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes